- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
MST1 mediates doxorubicin-induced cardiomyopathy by SIRT3 downregulation ; volume:80 ; number:9 ; day:11 ; month:8 ; year:2023 ; pages:1-16 ; date:9.2023
Cellular and molecular life sciences ; 80, Heft 9 (11.8.2023), 1-16, 9.2023
- Urheber
-
Schirone, Leonardo
Vecchio, Daniele
Valenti, Valentina
Forte, Maurizio
Relucenti, Michela
Angelini, Annalisa
Zaglia, Tania
Schiavon, Sonia
D’Ambrosio, Luca
Sarto, Gianmarco
Stanzione, Rosita
Mangione, Elisa
Miglietta, Selenia
Di Bona, Anna
Fedrigo, Marny
Ghigo, Alessandra
Versaci, Francesco
Petrozza, Vincenzo
Marchitti, Simona
Rubattu, Speranza
Volpe, Massimo
Sadoshima, Junichi
Frati, Luigi
Frati, Giacomo
Sciarretta, Sebastiano
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00018-023-04877-7
- URN
-
urn:nbn:de:101:1-2023112313103736283996
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:36 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Schirone, Leonardo
- Vecchio, Daniele
- Valenti, Valentina
- Forte, Maurizio
- Relucenti, Michela
- Angelini, Annalisa
- Zaglia, Tania
- Schiavon, Sonia
- D’Ambrosio, Luca
- Sarto, Gianmarco
- Stanzione, Rosita
- Mangione, Elisa
- Miglietta, Selenia
- Di Bona, Anna
- Fedrigo, Marny
- Ghigo, Alessandra
- Versaci, Francesco
- Petrozza, Vincenzo
- Marchitti, Simona
- Rubattu, Speranza
- Volpe, Massimo
- Sadoshima, Junichi
- Frati, Luigi
- Frati, Giacomo
- Sciarretta, Sebastiano
- SpringerLink (Online service)
Ähnliche Objekte (12)
Calsyntenin-1 Promotes Doxorubicin-induced Dilated Cardiomyopathy in Rats
Doxorubicin-induced ovarian toxicity
Embryonic stem cell-derived cardiomyocytes for the treatment of doxorubicin-induced cardiomyopathy
Role of oxidative stress and inflammation-related signaling pathways in doxorubicin-induced cardiomyopathy
Major vault protein attenuates cardiomyocyte injury in doxorubicin-induced cardiomyopathy through activating AKT
Prophylactic, single-drug cardioprotection in a comparative, experimental study of doxorubicin-induced cardiomyopathy
Empagliflozin prevents doxorubicin-induced myocardial dysfunction
Human induced pluripotent stem cell models used in the study of doxorubicin-induced cardiomyopathy
Doxorubicin-induced cardiomyopathy associated with inhibition of autophagic degradation process and defects in mitochondrial respiration
Red ginseng prevents doxorubicin-induced cardiomyopathy by inhibiting cell death via activating the Nrf2 pathway
Cardiomyocyte-specific knockout of ADAM17 alleviates doxorubicin-induced cardiomyopathy via inhibiting TNFα–TRAF3–TAK1–MAPK axis
Rifampicin efficacy against doxorubicin-induced cardiotoxicity in mice
Calsyntenin-1 Promotes Doxorubicin-induced Dilated Cardiomyopathy in Rats
Doxorubicin-induced ovarian toxicity
Embryonic stem cell-derived cardiomyocytes for the treatment of doxorubicin-induced cardiomyopathy
Role of oxidative stress and inflammation-related signaling pathways in doxorubicin-induced cardiomyopathy
Major vault protein attenuates cardiomyocyte injury in doxorubicin-induced cardiomyopathy through activating AKT
Prophylactic, single-drug cardioprotection in a comparative, experimental study of doxorubicin-induced cardiomyopathy
Empagliflozin prevents doxorubicin-induced myocardial dysfunction
Human induced pluripotent stem cell models used in the study of doxorubicin-induced cardiomyopathy
Doxorubicin-induced cardiomyopathy associated with inhibition of autophagic degradation process and defects in mitochondrial respiration
Red ginseng prevents doxorubicin-induced cardiomyopathy by inhibiting cell death via activating the Nrf2 pathway
Cardiomyocyte-specific knockout of ADAM17 alleviates doxorubicin-induced cardiomyopathy via inhibiting TNFα–TRAF3–TAK1–MAPK axis
Rifampicin efficacy against doxorubicin-induced cardiotoxicity in mice
Calsyntenin-1 Promotes Doxorubicin-induced Dilated Cardiomyopathy in Rats
Doxorubicin-induced ovarian toxicity
Embryonic stem cell-derived cardiomyocytes for the treatment of doxorubicin-induced cardiomyopathy
Role of oxidative stress and inflammation-related signaling pathways in doxorubicin-induced cardiomyopathy
Major vault protein attenuates cardiomyocyte injury in doxorubicin-induced cardiomyopathy through activating AKT
Prophylactic, single-drug cardioprotection in a comparative, experimental study of doxorubicin-induced cardiomyopathy
Empagliflozin prevents doxorubicin-induced myocardial dysfunction
Human induced pluripotent stem cell models used in the study of doxorubicin-induced cardiomyopathy
Doxorubicin-induced cardiomyopathy associated with inhibition of autophagic degradation process and defects in mitochondrial respiration
Red ginseng prevents doxorubicin-induced cardiomyopathy by inhibiting cell death via activating the Nrf2 pathway
Cardiomyocyte-specific knockout of ADAM17 alleviates doxorubicin-induced cardiomyopathy via inhibiting TNFα–TRAF3–TAK1–MAPK axis